Scott Sanborn
Analyst · JPMorgan. Please proceed.
Yeah. Hey, Reggie. So, I'll try to touch on this. It really depends on what segment of the market you're talking about. So, in, let's call it, the near prime portion of the portfolio where the competition is non-bank lenders, that includes fintech, but also specialty finance companies, whose cost of funds is moving and locked up with the forward curve, we are able to pass the price on, and indeed, we've done that already. So, the pricing on our near prime portfolio that we're -- we don't hold that, but the stuff we're issuing is actually pretty close to the amount that the Fed has already moved. But in the prime space, we've moved up credit quality, given the environment we're in. And given the outlook, we've moved most of our origination upmarket, both for what we hold, but also what we sell, because that's where the investor interest is highest right now. We're competing with banks, right? And so, you can think about our ability to move prices corresponding somewhat to bank betas on their deposit, right? Banks are moving as they're realizing their own cost of funding going up, that lags, right? And so, pricing, we're always in the market testing in a variety of price points. So, we are monitoring that through the door of population to make sure we understand what we're getting, and that the population is stable. And so, we are moving as we can. As we see take rates stabilize at higher price points and population stabilize, we move. But because we're competing with banks there, that's just at a different rate.